- Home
- CLST vs TLPH Comparison
CLST vs TLPH Comparison
Compare CLST & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- TLPH
- Stock Information
- Founded
- CLST 1922
- TLPH 2005
- Country
- CLST United States
- TLPH United States
- Employees
- CLST N/A
- TLPH N/A
- Industry
- CLST
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- TLPH Health Care
- Exchange
- CLST Nasdaq
- TLPH Nasdaq
- Market Cap
- CLST 54.6M
- TLPH 64.7M
- IPO Year
- CLST N/A
- TLPH 2011
- Fundamental
- Price
- CLST $14.25
- TLPH $1.23
- Analyst Decision
- CLST
- TLPH Strong Buy
- Analyst Count
- CLST 0
- TLPH 1
- Target Price
- CLST N/A
- TLPH $6.00
- AVG Volume (30 Days)
- CLST 11.3K
- TLPH 308.0K
- Earning Date
- CLST 10-23-2025
- TLPH 11-12-2025
- Dividend Yield
- CLST N/A
- TLPH N/A
- EPS Growth
- CLST N/A
- TLPH N/A
- EPS
- CLST 0.60
- TLPH N/A
- Revenue
- CLST $11,340,000.00
- TLPH $27,000.00
- Revenue This Year
- CLST N/A
- TLPH N/A
- Revenue Next Year
- CLST N/A
- TLPH $14,533.26
- P/E Ratio
- CLST $24.42
- TLPH N/A
- Revenue Growth
- CLST 133.67
- TLPH N/A
- 52 Week Low
- CLST $10.67
- TLPH $0.38
- 52 Week High
- CLST $15.30
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- CLST 63.55
- TLPH 55.08
- Support Level
- CLST $14.01
- TLPH $1.12
- Resistance Level
- CLST $15.30
- TLPH $1.42
- Average True Range (ATR)
- CLST 0.37
- TLPH 0.09
- MACD
- CLST 0.08
- TLPH -0.02
- Stochastic Oscillator
- CLST 49.03
- TLPH 45.59
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.